68 related articles for article (PubMed ID: 22555486)
1. Plasma angiogenin and vascular endothelial growth factor a among hemodialysis patients.
Eleftheriadis T; Antoniadi G; Liakopoulos V; Pissas G; Stefanidis I; Galaktidou G
Iran J Kidney Dis; 2012 May; 6(3):209-15. PubMed ID: 22555486
[TBL] [Abstract][Full Text] [Related]
2. Plasma indoleamine 2,3-dioxygenase concentration is increased in hemodialysis patients and may contribute to the pathogenesis of coronary heart disease.
Eleftheriadis T; Antoniadi G; Liakopoulos V; Stefanidis I; Galaktidou G
Ren Fail; 2012; 34(1):68-72. PubMed ID: 22017594
[TBL] [Abstract][Full Text] [Related]
3. Increased plasma angiogenin level is associated and may contribute to decreased T-cell zeta-chain expression in hemodialysis patients.
Eleftheriadis T; Kartsios C; Pissas G; Liakopoulos V; Antoniadi G; Galaktidou G; Stefanidis I
Ther Apher Dial; 2013 Feb; 17(1):48-54. PubMed ID: 23379493
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin and E-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease(s).
El-Mesallamy HO; Hamdy NM; Salman TM; Mahmoud S
Minerva Endocrinol; 2011 Sep; 36(3):163-70. PubMed ID: 22019747
[TBL] [Abstract][Full Text] [Related]
5. Plasma vascular endothelial growth factor and angiogenin are positively related to erythropoietin dose in hemodialysis patients.
Eleftheriadis T; Antoniadi G; Liakopoulos V; Pissas G; Galaktidou G; Stefanidis I
Adv Med Sci; 2013; 58(1):143-9. PubMed ID: 23640951
[TBL] [Abstract][Full Text] [Related]
6. Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression.
Molica S; Vitelli G; Levato D; Giannarelli D; Vacca A; Cuneo A; Ribatti D; Digiesi G
Eur J Haematol; 2004 Jul; 73(1):36-42. PubMed ID: 15182336
[TBL] [Abstract][Full Text] [Related]
7. Decreased angiogenin concentration in vitreous and serum in proliferative diabetic retinopathy.
Marek N; Raczyńska K; Siebert J; Myśliwiec M; Zorena K; Myśliwska J; Reiwer-Gostomska M; Trzonkowski P
Microvasc Res; 2011 Jul; 82(1):1-5. PubMed ID: 21539846
[TBL] [Abstract][Full Text] [Related]
8. Role of novel biomarkers of inflammation in patients with stable coronary heart disease.
Oren H; Erbay AR; Balci M; Cehreli S
Angiology; 2007; 58(2):148-55. PubMed ID: 17495262
[TBL] [Abstract][Full Text] [Related]
9. Determinants of C-reactive protein in chronic hemodialysis patients: relevance of dialysis catheter utilization.
Hung A; Pupim L; Yu C; Shintani A; Siew E; Ayus C; Hakim RM; Ikizler TA
Hemodial Int; 2008 Apr; 12(2):236-43. PubMed ID: 18394058
[TBL] [Abstract][Full Text] [Related]
10. Circulating serum levels of angiogenic factors and vascular endothelial growth factor receptors 1 and 2 in melanoma patients.
Tas F; Duranyildiz D; Oguz H; Camlica H; Yasasever V; Topuz E
Melanoma Res; 2006 Oct; 16(5):405-11. PubMed ID: 17013089
[TBL] [Abstract][Full Text] [Related]
11. Serum concentrations of angiogenic cytokines in Waldenstrom macroglobulinaemia: the ration of angiopoietin-1 to angiopoietin-2 and angiogenin correlate with disease severity.
Anagnostopoulos A; Eleftherakis-Papaiakovou V; Kastritis E; Tsionos K; Bamias A; Meletis J; Dimopoulos MA; Terpos E
Br J Haematol; 2007 Jun; 137(6):560-8. PubMed ID: 17451406
[TBL] [Abstract][Full Text] [Related]
12. Effect of the hemodialysis membrane on the inflammatory reaction in vivo.
Schindler R; Boenisch O; Fischer C; Frei U
Clin Nephrol; 2000 Jun; 53(6):452-9. PubMed ID: 10879665
[TBL] [Abstract][Full Text] [Related]
13. Plasma lipoprotein Lp(a), markers of haemostasis and inflammation, and risk and severity of coronary heart disease.
Imhof A; Rothenbacher D; Khuseyinova N; Hoffmeister A; Maerz W; Nauck M; Scharnagl H; Koenig W; Brenner H
Eur J Cardiovasc Prev Rehabil; 2003 Oct; 10(5):362-70. PubMed ID: 14663298
[TBL] [Abstract][Full Text] [Related]
14. Elevated circulating levels of soluble CD-40 ligand in haemodialysis patients with symptomatic coronary heart disease.
Lim PS; Wu MY; Chien SW; Wu TK; Liu CS; Hu CY; Chang HC; Pai MA
Nephrology (Carlton); 2008 Dec; 13(8):677-83. PubMed ID: 19019166
[TBL] [Abstract][Full Text] [Related]
15. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
[TBL] [Abstract][Full Text] [Related]
16. Levels of soluble angiogenin in chronic myeloid malignancies: clinical implications.
Musolino C; Alonci A; Bellomo G; Loteta B; Quartarone E; Gangemi D; Massara E; Calabrò L
Eur J Haematol; 2004 Jun; 72(6):416-9. PubMed ID: 15128420
[TBL] [Abstract][Full Text] [Related]
17. Impact of the Thr789Ala variant of the von Willebrand factor levels, on ristocetin co-factor and collagen binding capacity and its association with coronary heart disease in patients with diabetes mellitus type 2.
Klemm T; Mehnert AK; Siegemund A; Wiesner TD; Gelbrich G; Blüher M; Paschke R
Exp Clin Endocrinol Diabetes; 2005 Dec; 113(10):568-72. PubMed ID: 16320153
[TBL] [Abstract][Full Text] [Related]
18. Increased peripheral circulating inflammatory cells and plasma inflammatory markers in patients with variant angina.
Li JJ; Zhang YP; Yang P; Zeng HS; Qian XW; Zhang CY; Zhu CG; Li J; Nan JL
Coron Artery Dis; 2008 Aug; 19(5):293-7. PubMed ID: 18607165
[TBL] [Abstract][Full Text] [Related]
19. Plasma indices of angiogenesis in rheumatoid disease: relationship to cardiovascular risk factors and cardiac function.
Bhatia GS; Sosin MD; Patel JV; Grindulis KA; Khattak FH; Davis RC; Lip GY
Int J Cardiol; 2010 Dec; 145(3):e105-8. PubMed ID: 19185362
[TBL] [Abstract][Full Text] [Related]
20. Endothelial dysfunction in patients with kidney failure and vascular risk factors: acute effects of hemodialysis.
Migliacci R; Falcinelli F; Imperiali P; Floridi A; Nenci GG; Gresele P
Ital Heart J; 2004 May; 5(5):371-7. PubMed ID: 15185901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
